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Long-TermStabilityof a StabilizedLiquidQuality-ControlSerum
Alfred E. Hartmann,’ Richard D. Juel,2 and Roy N Barnett3
To evaluate the long-term stability of a new liquid qual-
ity-control serum (“Decision”, Beckman Instruments, Inc.)
stabilized with ethylene glycol (330 mL/L), we analyzed
it for 22 Commonly measured analytes during storage at
2-8 #{176}Cfor 24 days or -15 to -20 #{176}Cfor 55 weeks. Three
separate laboratories replicated the analyses, using vari-
ous analytical methodologies. The data were subjected to
linear regression analysis, regressing concentration on
time. Analytes were considered unstable when the linear
regression coefficient was unequal to zero with 95% or
greater probability in all three laboratories. By this criterion
all of the analytes were stable for at least 24 days when
the control serum was stored at refrigerator temperature
and for at least 55 weeks at freezer temperature. We
conclude this material is a satisfactory substitute for ex-
isting lyophilized quality-control materials and offers
certain advantages: stability, vial-to-vial uniformity, de-
creased waste, and eliminated reconstitution.
Short- and long-term monitoring of accuracy and precision
usually involves periodic analysis of frozen pooled serum or
commercially available lyophilized serum. Frozen pooled
serum has limited stability, and so is validly useful for rela-
tively short times (1-5). Lyophilized serum has been associ-
ated with problems of analyte instability, both in the lyophi-
lized form and in the reconstituted material (6-13). In addi-
tion, lyophilized serum has potential errors associated with
bottle-to-bottle variation that originate from incomplete vial
filling and lyophilization, variations in moisture content, de-
naturation of lipoproteins, turbidity, and variations in mea-
surement of diluent used for reconstitution (14, 15). Cumu-
latively, these sources of instability and variability can lead
to a large variation in quality-control data within a laboratory
aswell as in interlaboratory external quality-control programs,
variation that is in addition to the inherent imprecision of the
method.
Recently a series of stabilized liquid quality-control sera
and calibrators (Decision1M, QuantitateTM, and Benchmark1M;
Beckman Instruments Inc., Fullerton CA 92634) have been
introduced in which ethylene glycol is used as a stabilizer.
These products consist of clear, straw-colored, homogeneous
pooled serum stabilized with 330 mL of ethylene glycol per
liter, which allows the material to remain liquid to at least -20
#{176}C(16). These products offer several advantages over previous
quality-control materials: no need for reconstitution, vial-
to-vial uniformity, decreased waste, and the potential of
long-term stability of various analytes.
This report describes our experience with the long-term
stability of one of these new products, Decision’5 Level 3, a
comprehensive chemistry liquid control serum with analyte
concentrations in the high range, near the upper critical
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medical-decision value for each analyte (17). We evaluated
this material for stability on storage at two temperatures:
refrigerator (2 to 8 #{176}C),for short-term storage, and freezer
(-15 to -20 #{176}C),for long-term storage. Our three separate
laboratories analyzed 22 analytes-enzymes and inorganic and
organic analytes most commonly determined in the clinical
chemistry laboratory.
Materials and Methods
Decision Level 3 was sent on ice by the manufacturer to
each of three laboratories, packaged in 20-mL plastic squeeze
bottles. Upon receipt of the material, part of it was stored in
the refrigerator at 2 to 8 #{176}Cand the rest in the freezer at -15
to -20 #{176}C.The refrigerator-stored material was sampled and
analyzed in duplicate every other day during 24 days. The
freezer-stored material was sampled and analyzed in duplicate
every other week for 55 weeks. Aliquots of the material were
allowed to equilibrate to room temperature before analysis.
The assays were done by including the samples randomly in
the daily workload of each laboratory.
Laboratory H (Hartmann) used an SMA 12/60 (Technicon
Instruments Corp., Tarrytown, NY 10591) with unmodified
Technicon methodologies to analyze for ttie following analytes
by the methods indicated: calcium, o-cresolphthalein com-
plexone; phosphorus, phosphomolybdate; urea nitrogen, di-
acetyl monoxime; uric acid, phosphotungstate; glucose, glu-
cose oxidase; cholesterol, cholesterol oxidase; total protein,
biuret; albumin, bronicresol green; bilirubin, Jendrassik and
Grof; alkaline phosphatase (EC 3.1.3.1), p-nitrophenyl
phosphate; lactate dehydrogenase (EC 1.1.1.27, LDH),4 lac-
tate-NAD; and aspartate aminotransferase (EC 2.6.1.1,
AST), malate dehydrogenase-NADH (18). A CentrifiChem
(Union Carbide Corp., Rye, NY 10580) was used to analyze
for creatine kinase (EC 2.7.3.2, CPK), Oliver, hexokinase-
glucose-6-phosphate dehydrogenase-NADP (19); creatinine,
kinetic alkaline picrate (19); alanine aminotransferase (EC
2.6.1.2, ALT), LDH-pyruvate-NADH (20); and triglycerides,
glycerol kinase-pyruvate kinase (21). Additional analyses
included iron, ferrozine (22); magnesium, fluorometric (23);
sodium and potassium, flame photometry (KLiNa Flame;
Beckman Instruments Inc.); and chloride and CO2 (Cl/CO2
Analyzer; Beckman Instruments Inc.).
Laboratory J (Juel) used a SMAC (Technicon Instruments
Corp.) and standard Technicon methodologies to analyze for
the following analytes: calcium, o-cresolphthalemn complexone;
phosphorus, phosphomolybdate; urea nitrogen, diacetyl
monoxime; glucose, glucose oxidase; uric acid, phosphotung-
state; cholesterol, Liebermann-Burchard; total protein, biuret;
albumin, bromcresol green; bilirubin, Jendrassik and Grof;
alkaline phosphatase, p- nitrophenyl phosphate; lactate de-
hydrogenase, lactate_NAD+; aspartate aminotransferase,
malate dehydrogenase-NADH; alanine aminotransferase,
pyruvate-LDH-NADH; sodium and potassium, ion-selective
electrodes; chloride, mercuric thiocyanate; carbon dioxide,
phenolphthalein; creatinine, alkaline picrate; and triglycer-
ides, glycerol kinase-pyruvate kinase (24). Iron,magnesium,
and creatine kinase were not measured in this laboratory.
Nonstandard abbreviations: LDH, lactate dehydrogenase; CPK,
creatine kinase; AST, aspartate aminotransferase; ALT, alanine
aminotransferase.
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In Laboratory B (Barnett) an SMA 6/60 (Technicon In-
struments Corp.) was used to analyze for sodium and potas-
sium, flame photometry; chloride, thiocyanate; carbon diox-
ide, phenolphthalein; urea nitrogen, diacetyl monoxime; and
glucose, glucose oxidase (25). Magnesium was analyzed by
atomic absorption spectroscopy (26). An AutoAnalyzer I
(Technicon Instruments Corp.) wasused to analyze for cre-
atinine, alkaline picrate; calcium, cresolphthalein complexone;
bilirubin, Jendrassik and Grof; total protein, biuret (27); al-
bumin, bromcresol green (28); and iron, bathophenanthroline
(29). An ABA-100 (Abbott Laboratories Diagnostic Division,
South Pasadena, CA 91030) was used to analyze for choles-
terol, cholesterol oxidase; triglyceride, glycerol kinase-pyru-
vate kinase; creatine kinase, Oliver, hexokinase-glucose-6-
phosphate dehydrogenase-NADP; lactate dehydrogenase,
lactate-NAD; aspartate aninotransferase, malate dehy-
drogenase-NADH; alanine aminotransferase, pyruvate-
LDH-NADH; alkaline phosphatase, p-nitrophenyl phosphate
(30); and phosphorus, phosphomolybdate (31).
We collated and analyzed the data by linear regression
analysis, regressing analyte concentration (y) vs time (x). The
general expression for linear regression used for this study is:
Y = a + bx1,where Y, is the predicted value of the analyte
concentration, a is the intercept value of Y, at x1 = 0, b is the
slope or trend of analyte concentration with time, and x1is the
measure of time (days or weeks) (32). The slope (b) and




SEb = [(y1 - Y1)2/[(n - 2) (x1 - y2j1/2
where y, is the actual analyte concentration; I’, is the predicted
value of the analyte concentration corresponding to a given
x value calculated from the linear regression equation Y1 =
a + bx1;x, is the number of the day or week; and 7 is the mean
value over the time period studied, in days or weeks. The
concentration of an analyte was considered to drift with time
when the slope (b) of analyte concentration vs time was un-
equal to zero with 95% or greater probability. This assessment
was made by taking the slope (b) ±t times the standard error,
where t is the p = 0.975 value with (n - 2) degrees of freedom
(34). When these 95% confidence limits of the slope (b) do not
include zero, it has been demonstrated that changes in con-
centration are not independent of time with 95% or greater
probability. A significant positive slope (b) indicates a general
trend over time for the apparent analyte concentration to
increase, while a significant negative slope (b) indicates a
general trend over time for it to decrease. If an analyte is truly
unstable, one would expect a significant change in concen-
tration over the time periods studied in each of the three
laboratories.
Results
Table 1 illustrates the tabulated stability results for the
liquid control material stored at refrigerator temperature (2
to 8 C) for 24 days. Alkaline phosphatase, AST, LDH, CPK,
sodium,chloride,carbondioxide,magnesium, inorganic
phosphate, urea nitrogen, uric acid, triglycerides, and albumin
were found to be stable by all three laboratories. For creatinine
the findings were no change, 4% gradual increase, and a 4%
gradual decrease in concentration with time in the three lab-
oratories, respectively, unaccompanied by any significant
quality-control trends. The remaining analytes each demon-
strated a significant concentration change with time in one
of the laboratories and stable results in the other two. ALT
showed a significant decrease in activity in Laboratory J, ac-
companied by a simultaneous significant negative slope with
time of the routine quality-control material, indicating a
possible reagent or instrument drift to be the reason for the
apparent ALT instability. Laboratory H found potassium and
iron to be stable for 17 days and 21 days, respectively, before
a decrease in concentration of 4% was noted in both instances.
There was a corresponding downward shift in the routine
quality-control serum in this laboratory, again indicating re-
agent or analytical system drift as the possible explanation
of the apparent instability. In one of the laboratories there
were significant concentration changes for calcium, glucose,
bilirubin, cholesterol, and total protein that were gradual and
unaccompanied by corresponding concentration changes in
the regular quality-control material except for cholesterol in
Laboratory H, where erratic results were due to instrument
problems (clot and phasing).
Table 2 summarizes our stabilitydata for the liquid material
stored at freezer temperature for 55 weeks. CPK, LDH, ALT,
AST, sodium, chloride magnesium, glucose, uric acid, and
triglycerides were found to be stable by all three laboratories.
Bilirubin concentration shifted downwards (7 mg/L) during
the tenth month in Laboratory J, corresponding to a down-
ward change in the reference value used in calibrating the
instrument. The potassium data from Laboratory B were
consistent for six months, then there was a significant down-
ward shift for five months, and finally there was an upward
shift during the last month to the original concentration. The
decrease in the apparent concentration of inorganic phosphate
in Laboratory H was accompanied by an associated downward
shift in the routine quality-control material. Alkaline phos-
phatase, calcium, iron, cholesterol, and total protein each
showed a gradual concentration trend with time in one of the
laboratories, unassociated with demonstrable reagent or an-
alytical system drift. The creatinine values obtained in Lab-
oratory J remained unchanged for nine months, then gradu-
ally increased by 10 mg/L at the end of the 55-week period,
a phenomenon not seen in the other two laboratories. Carbon
dioxide showed a significant downward concentration trend
in two of the laboratories (H, J) and a statistically insignificant
downward trend in the third. In all three laboratories the
downward trend was gradual, with a maximum decrease of 2
mmol/L. Urea nitrogen showed a significant upward shift in
concentration in two of the laboratories (B, J). In both labo-
ratories the urea nitrogen value remained unchanged for 10
months and then increased by 30 to 50 mg/L during the last
two months of the study, a phenomenon not seen by the third
laboratory (H).
A review of the data reveals that none of the analytes in the
liquid material stored in the refrigerator for 24 days or in the
freezer for 55 weeks demonstrated a concurrent significant
deviation with time in all three laboratories. For each time
period studied, the long-term precision (SD) of each analyte
in the liquid control material was equivalent to the precision
of the regular quality-control material that was being used in
each laboratory.
Discussion
Ethylene glycol has previously been reported to be effective
in stabilizing analytes in pooled serum (16,35). The stabilizing
effects of ethylene glycol are apparently attributable to the
high osmolality, minimizing bacterial growth; the antioxidant
properties, stabilizing oxygen-labile constituents; and the
depression of the freezing point, allowing the serum to remain
in the liquid state at -20 #{176}C(17).
Analyte stability has been variously defined in the literature
from simply visually inspecting the data for trends in con-
centration with time without formal statistical analysis to
utilizing persistence of analyte concentration within defined
precision limits, without a general consensus as to a definition


































0.06 -0.574 0.199 D


















































1.0 -0.003 0.003 S
3.0 -0.000 0.011 S














































































































































H 117 3.7 -0.037
B 114 1.8 0.090
J 112 1.4 -0.006
Carbon dioxide, mmol/L
H 32 1.3 -0.016
B 31 1.6 -0.014












asignificance at the p=.05 level expressed as S = Stable, D = Significant decrease, and
I = Significant increase in concentration with time.
ofacceptable stability(6-8, 36). We chose to utilize the rig-
orous approach of Lawson et al. (32) to stability, which con-
sists of linear regression analysis, regressing analyte concen-
tration vs time, and defining instability to exist when the slope
of the regression line is unequal to zero at the p <0.05 level.
Subtle trends in changes of analyte concentration with time
can be detected by this method that may not be evident by
criteria based on analyte concentration exceeding predeter-
mined limits of analytical precision. Because of the statistical
method chosen, about 5% of the analytes would be expected
to show statistical instability even when the analyte was in fact
stable. Moreover, a shift in the analytical method due to in-
strument or reagent variability and not detected by the lab-
oratory’s usual quality-control procedures would also give rise
to apparent instability for truly stable analytes. For these
reasons, if an analyte is in fact unstable in the liquid material,
the slope of analyte concentration vs time would be expected
to deviate significantly from zero in the same direction in all
three laboratories that were concurrently analyzing a single
pool of the liquid material.
The data reveal that none of the analytes showed a consis-
tent deviation of concentration with time for the liquid ma-
terial stored either for 24 days at refrigerator temperature or
for 55 weeks at freezer temperature. This was true even of the
enzymes, among the most labile of chemical analytes. Several
analytes showed a significant change in concentration with
time in at least one of the laboratories. In some instances the
quality-control serum routinely used for that analyte also
showed a similar concentration change with time, indicating
that a drift in the analytical system caused the analyte con-
centration to appear to change with time. In other instances
we could not explain a statistically significant deviation of
Table 2. Summary of Data from Liquid Control Material Stored at Freezer Temperature (-15 to
-20 #{176}C)for 55 Weeks
Regression

















































-0.0774 0.1056 S H 24 2.0
0.5199 0.4318 5 B 214 2.0
Iron, mg/L
0.1243 S Fl 1.87 0.09
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I B 6.7 0.2








































































































































































































aSimificanCe at the p.05 level expressed
I Significant increase in concentration
as S Stable, D Significant decrease, and
with time.
concentration with time for an analyte in one laboratory with
no evidence of such a concentration change in the other two
laboratories. The data do suggest possible instability in carbon
dioxide and urea nitrogen in the freezer-stored material during
the year of storage. Both of these analytes showed significant
concentration trends in two of the laboratories but stable re-
sults in the third laboratory. A simultaneous evaluation of
Decision Level 1 and Decision’s Level 2 (Beckman Instru-
ments, Inc.) liquid control materials, which have analyte
concentrations in the low and normal ranges, respectively, did
not reveal any significant concentration change for these two
analytes. Our results for the remaining analytes were essen-
tially the same as reported here for Decision” Level 3. Frajola
and Maurakas (16) evaluated a liquid reference serum stabi-
lized with ethylene glycol, the prototype on which the Decision
material was based, and found stable results for 18 different
analytes, including carbon dioxide and urea nitrogen, for as
long as 568 days when the material was stored at -20 #{176}C.
Several additional characteristics and properties of this
liquid material deserve mention. The material was negative
for hepatitis B surface antigen according to licensed third-
generation testing. It had a freezing point of -23 #{176}C.Freezing
the material did not seem to affect any results adversely. A
vial-to-vial study (publication in process) revealed insignifi-
cant bottle-to-bottle variation. Because the material is liquid,
reconstitution is eliminated, which obviates a source of po-
tential error and saves technologist time. Lastly, aliquots of
material can be removed from the dispenser bottle, the re-
mainder being stored until needed, thus avoiding waste of
material.
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